Chinese Firm Overstates Cash by $4.3 Billion Using False Documents

Bookmark
(Bloomberg) -- One of China’s largest listed drug makers that’s been under a regulatory probe for months said it overstated cash positions after using false documents and transaction records. The s...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.